Press Releases 2014

Boston Scientific Announces Pacemaker CE Mark With Options For Magnetic Resonance Imaging - Oct 16, 2014

Boston Scientific Corporation (NYSE: BSX) has received CE Mark approval for the ACCOLADETM pacemaker family. When implanted with the company's INGEVITYTM leads...

Read more

Boston Scientific announces new developments in its Electrophysiology portfolio - Oct 02, 2014

Boston Scientific is leading the way in developing innovative cardiac rhythm management technologies, designed to improve health outcomes for patients suffering from arrhythmias...

Read more

Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial - Aug 30, 2014

Phase II feasibility trial provides first randomized sham-controlled data using vagus nerve stimulation to treat heart failure.

Read more

Boston Scientific at Cardiostim 2014 - Jul 11, 2014

A short video summary of Cardiostim 2014, featuring interviews with Dr Maria Grazia Bongiorni, Dr Michele Gulizia and Prof. Andreas Bollmann on the S-ICD™ System and the..

Read more

Boston Scientific welcomes new guidance on the use of cardiac technologies for patients with arrhythmia or heart failure - Jun 26, 2014

Boston Scientific welcomes the National Institute for Health and Care Excellence (NICE) guidance on the use of implantable cardioverter defibrillators (ICDs) and cardiac...

Read more

New Data Illustrate Long-Term Safety And Effectiveness Of The Boston Scientific S-ICD™ System - Apr 01, 2014

Real-world data on the Boston Scientific Corporation (NYSE:BSX) S-ICD System (Subcutaneous Implantable Defibrillator) are highlighted online this week in the European Heart Journal.

Read more

New Long-term Data Demonstrate Patients with Mild Heart Failure Sustained Lower Mortality Rates After Receiving Boston Scientific CRT Defibrillators - Mar 30, 2014

In the longest follow-up to date of cardiac resynchronization therapy (CRT) for mild heart failure patients, Boston Scientific Corporation's (NYSE: BSX) exclusively sponsored and...

Read more

Boston Scientific Announces CE Mark Approval and First Implants of Ingevity™ MRI Pacing Leads - Mar 14, 2014

Boston Scientific Corporation (NYSE: BSX) announces CE Mark approval and European market launch of the INGEVITY™ family of magnetic resonance imaging (MRI) compatible pacing leads.

Read more

Media Contacts

Rosie Ireland
Corporate Communications
+44 7585403359

Company Profile